Neurovalens to raise £5M in an equity deal led by Clarendon Fund Managers
09 August 2025
09 August 2025
Total investments received (USD): 17.3M
Round value (USD): 6.75M
Company: Neurovalens
Related deals
Ceryx Medical raised £5M with Development Bank of Wales, Parkwalk Advisors
Investments
03 June 2025
Samphire Neuroscience raises a $5M seed round with Inventure, Fortify Ventures and APEX Capital
Investments
30 May 2025
Signatur Biosciences closed a $7 million seed round led by The Discovery Lab of IBA, joined by Noshaq and YC
Investments
12 May 2025
Neuranics raised $8 million in seed led by Blackfinch Ventures, joined by Archangels, Par Equity, the University of Glasgow, and Old College Capital,
Investments
02 April 2025
CSignum in a €6.9 million Series A funding with Archangels, Par Equity, and Scottish Enterprise
Investments
02 April 2025
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Iceland
Latvia
Norway
Sweden
France
Ireland
Italy
Spain